uncontrolled gout Horizon Pharma Krystexxa
Horizon enrols first patient in Phase ll of Krystexxa and methotrexate
Horizon Pharma has enrolled the first patient in a Phase ll MIRROR clinical trial investigating Krystexxa (pegloticase injection) in combination…